Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENSC Ensysce Biosciences Inc.

盘前交易 05-05 08:30:45 EDT

2.57

-0.40

-13.47%

盘前2.59

+0.02+0.78%

08:00 EDT

最高2.91	最低2.50	成交量19.76万
今开2.83	昨收2.97	日振幅13.80%
总市值422.70万	流通市值291.98万	总股本164.47万
成交额52.27万	换手率17.39%	流通股本113.61万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENSC","market":"US","secType":"STK","nameCN":"Ensysce Biosciences Inc.","latestPrice":2.57,"timestamp":1746216000000,"preClose":2.97,"halted":0,"volume":197552,"hourTrading":{"tag":"盘前","latestPrice":2.59,"preClose":2.57,"latestTime":"08:00 EDT","volume":56,"amount":145.08999680000002,"timestamp":1746446400422},"delay":0,"floatShares":1136100,"shares":1644728,"eps":-11.448165,"marketStatus":"盘前交易","change":-0.4,"latestTime":"05-05 08:30:45 EDT","open":2.83,"high":2.91,"low":2.5,"amount":522706.3334704,"amplitude":0.138047,"askPrice":2.81,"askSize":100,"bidPrice":2.5,"bidSize":5,"shortable":0,"etf":0,"ttmEps":-11.448165,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1746451800000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.57,"preHourTrading":{"tag":"盘前","latestPrice":2.59,"preClose":2.57,"latestTime":"08:00 EDT","volume":56,"amount":145.08999680000002,"timestamp":1746446400422},"postHourTrading":{"tag":"盘后","latestPrice":2.5899,"preClose":2.57,"latestTime":"19:44 EDT","volume":2320,"amount":5946.965,"timestamp":1746229464287},"volumeRatio":0.5147698764461457,"impliedVol":3.1521,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/ENSC/tweets","defaultTab":"tweets","newsList":[{"id":"2532580437","title":"Ensysce Biosciences, Inc.5月2日成交额为52.00万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532580437","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532580437?lang=zh_cn&edition=full","pubTime":"2025-05-03 09:30","pubTimestamp":1746235859,"startTime":"0","endTime":"0","summary":"美东时间2025年5月2日，Ensysce Biosciences, Inc.成交额为52.00万美元，成交额较昨日增加52.06%，当日成交量为19.76万股。Ensysce Biosciences, Inc.于2025年5月2日跌13.47%，报2.57美元，该股过去5个交易日跌21.88%，年初至今跌68.43%，过去60日跌58.48%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-05-02|52.00万|52.06%|19.76万|#|2025-05-01|34.20万|-24.18%|11.23万|#|2025-04-30|45.10万|-60.66%|14.99万|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503093102a6d19809&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250503093102a6d19809&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2532009618","title":"Ensysce Biosciences, Inc.盘中异动 早盘急速上涨5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532009618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532009618?lang=zh_cn&edition=full","pubTime":"2025-05-01 21:53","pubTimestamp":1746107583,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日21时53分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.30%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.40%。其相关个股中，Transcode Therapeutics, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Transcode Therapeutics, Inc.、Processa Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃，换手率分别为96.28%、35.37%、16.79%，振幅较大的相关个股有Transcode Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.，振幅分别为36.89%、24.75%、18.78%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121530394e9f955&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050121530394e9f955&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2532017637","title":"Ensysce Biosciences, Inc.4月30日成交额为45.10万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532017637","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532017637?lang=zh_cn&edition=full","pubTime":"2025-05-01 09:31","pubTimestamp":1746063078,"startTime":"0","endTime":"0","summary":"美东时间2025年4月30日，Ensysce Biosciences, Inc.成交额为45.10万美元，成交额较昨日减少60.66%，当日成交量为14.99万股。Ensysce Biosciences, Inc.于2025年4月30日跌0.98%，报3.02美元，该股过去5个交易日跌17.71%，年初至今跌62.9%，过去60日跌54.24%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-30|45.10万|-60.66%|14.99万|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093120a6cf869b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250501093120a6cf869b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2531742205","title":"Ensysce Biosciences, Inc.4月29日成交额为114.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531742205","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531742205?lang=zh_cn&edition=full","pubTime":"2025-04-30 09:30","pubTimestamp":1745976639,"startTime":"0","endTime":"0","summary":"美东时间2025年4月29日，Ensysce Biosciences, Inc.成交额为114.63万美元，成交额较昨日增加4.03%，当日成交量为37.35万股。Ensysce Biosciences, Inc.于2025年4月29日涨4.1%，报3.05美元，该股过去5个交易日涨63.1%，年初至今跌62.53%，过去60日跌55.6%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-29|114.63万|4.03%|37.35万|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093311a6ce1713&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430093311a6ce1713&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2531753471","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531753471","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531753471?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:54","pubTimestamp":1745934880,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时54分，Ensysce Biosciences, Inc.股票出现异动，股价急速拉升5.12%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为1.50%。其相关个股中，Cyclacel Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 涨幅较大，Zyversa Therapeutics, Inc.、Onconetix, Inc.、Galmed Pharmaceuticals Ltd.较为活跃，换手率分别为138.68%、57.20%、22.70%，振幅较大的相关个股有Spruce Biosciences, Inc.、Cyclacel Pharmaceuticals, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为31.68%、26.68%、22.81%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215440a6cd6f89&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429215440a6cd6f89&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2531216517","title":"Ensysce Biosciences, Inc.4月28日成交额为110.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531216517","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531216517?lang=zh_cn&edition=full","pubTime":"2025-04-29 09:30","pubTimestamp":1745890217,"startTime":"0","endTime":"0","summary":"美东时间2025年4月28日，Ensysce Biosciences, Inc.成交额为110.19万美元，成交额较昨日减少63.70%，当日成交量为37.02万股。Ensysce Biosciences, Inc.于2025年4月28日跌10.94%，报2.93美元，该股过去5个交易日涨76.51%，年初至今跌64.0%，过去60日跌56.33%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-28|110.19万|-63.70%|37.02万|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093143a46b403b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429093143a46b403b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2530428147","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速跳水5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530428147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530428147?lang=zh_cn&edition=full","pubTime":"2025-04-28 21:31","pubTimestamp":1745847098,"startTime":"0","endTime":"0","summary":"北京时间2025年04月28日21时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速跳水5.46%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Galmed Pharmaceuticals Ltd.、Cg Oncology, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Galmed Pharmaceuticals Ltd.、Portage Biotech Inc.、Tharimmune, Inc.较为活跃，换手率分别为1159.61%、310.57%、61.80%，振幅较大的相关个股有Portage Biotech Inc.、Galmed Pharmaceuticals Ltd.、Exozymes Inc.，振幅分别为16.55%、10.82%、10.07%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821313894e5f170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042821313894e5f170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2530115165","title":"Ensysce Biosciences, Inc.4月25日成交额为303.52万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530115165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530115165?lang=zh_cn&edition=full","pubTime":"2025-04-26 09:29","pubTimestamp":1745630989,"startTime":"0","endTime":"0","summary":"美东时间2025年4月25日，Ensysce Biosciences, Inc.成交额为303.52万美元，成交额较昨日减少43.39%，当日成交量为91.28万股。Ensysce Biosciences, Inc.于2025年4月25日跌0.6%，报3.29美元，该股过去5个交易日涨86.93%，年初至今跌59.58%，过去60日跌52.53%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-25|303.52万|-43.39%|91.28万|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|#|2025-04-21|13.83万|-40.66%|8.26万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092956a46786e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426092956a46786e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2530513008","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌6.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530513008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530513008?lang=zh_cn&edition=full","pubTime":"2025-04-25 21:32","pubTimestamp":1745587925,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日21时32分，Ensysce Biosciences, Inc.股票出现异动，股价急速下跌6.34%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.47%。其相关个股中，Azitra Inc、Lixte Biotechnology Holdings, Inc.、Geovax Labs, Inc.涨幅较大，Azitra Inc、Briacell Therapeutics Corp.、Acrivon Therapeutics, Inc.较为活跃，换手率分别为187.74%、41.72%、40.53%，振幅较大的相关个股有Azitra Inc、Polyrizon Ltd.、Acrivon Therapeutics, Inc.，振幅分别为13.07%、8.57%、8.22%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213206a6c81d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425213206a6c81d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2530945019","title":"Ensysce Biosciences, Inc.4月24日成交额为536.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530945019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530945019?lang=zh_cn&edition=full","pubTime":"2025-04-25 09:29","pubTimestamp":1745544554,"startTime":"0","endTime":"0","summary":"美东时间2025年4月24日，Ensysce Biosciences, Inc.成交额为536.19万美元，成交额较昨日减少98.52%，当日成交量为169.84万股。Ensysce Biosciences, Inc.于2025年4月24日跌9.81%，报3.31美元，该股过去5个交易日涨76.06%，年初至今跌59.34%，过去60日跌53.71%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-24|536.19万|-98.52%|169.84万|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|#|2025-04-21|13.83万|-40.66%|8.26万|#|2025-04-17|23.31万|-67.16%|13.33万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425092923a4661b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425092923a4661b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":1},{"id":"2529931887","title":"Ensysce Biosciences, Inc.股价重挫14.71% 市值跌75.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529931887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529931887?lang=zh_cn&edition=full","pubTime":"2025-04-24 21:32","pubTimestamp":1745501557,"startTime":"0","endTime":"0","summary":"北京时间2025年04月24日21时32分，Ensysce Biosciences, Inc.股票出现波动，股价急速跳水14.71%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.21%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Briacell Therapeutics Corp.、Cero Therapeutics Holdings, Inc.涨幅较大，Pmgc Holdings Inc.、Mustang Bio, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为587.58%、573.64%、550.17%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Briacell Therapeutics Corp C/Wts 26/02/2026、Briacell Therapeutics Corp.，振幅分别为38.78%、26.62%、20.99%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424213237a4656f38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424213237a4656f38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2529818618","title":"Ensysce Biosciences, Inc.4月23日成交额为3.62亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529818618","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529818618?lang=zh_cn&edition=full","pubTime":"2025-04-24 09:28","pubTimestamp":1745458123,"startTime":"0","endTime":"0","summary":"美东时间2025年4月23日，Ensysce Biosciences, Inc.成交额为3.62亿美元，成交额较昨日增加250819.29%，当日成交量为9205.43万股。Ensysce Biosciences, Inc.于2025年4月23日涨96.26%，报3.67美元，该股过去5个交易日涨63.84%，年初至今跌54.91%，过去60日跌49.79%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-23|3.62亿|250819.29%|9205.43万|#|2025-04-22|14.44万|4.38%|8.18万|#|2025-04-21|13.83万|-40.66%|8.26万|#|2025-04-17|23.31万|-67.16%|13.33万|#|2025-04-16|70.98万|-83.38%|36.78万|Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424092847a6c5df91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424092847a6c5df91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2529822606","title":"Ensysce Biosciences, Inc.盘中异动 股价大涨128.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529822606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529822606?lang=zh_cn&edition=full","pubTime":"2025-04-23 21:31","pubTimestamp":1745415073,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日21时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速上涨128.34%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Ensysce Biosciences, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Rezolute, Inc.涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为2743.53%、17.71%、7.88%，振幅较大的相关个股有Psyence Biomedical Ltd.、Immunocore Hldgs Plc、Ocean Biomedical, Inc.，振幅分别为9.34%、8.64%、7.79%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213113a6c53c4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213113a6c53c4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2529538480","title":"Ensysce Biosciences, Inc.盘中异动 急速拉升5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2529538480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529538480?lang=zh_cn&edition=full","pubTime":"2025-04-22 22:31","pubTimestamp":1745332277,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日22时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速上涨5.42%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.58%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Moolec Science Sa C/Wts 、阿诺医药涨幅较大，Ocean Biomedical, Inc.、Lipella Pharmaceuticals Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为194.16%、98.94%、87.48%，振幅较大的相关个股有Scorpius Holdings, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、60 Degrees Pharmaceuticals, Inc.，振幅分别为102.79%、44.71%、38.61%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422223117aa2c7651&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422223117aa2c7651&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2528743507","title":"Ensysce Biosciences, Inc.盘中异动 早盘大幅下挫6.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528743507","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528743507?lang=zh_cn&edition=full","pubTime":"2025-04-17 21:31","pubTimestamp":1744896683,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日21时31分，Ensysce Biosciences, Inc.股票出现异动，股价快速下挫6.91%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.47%。其相关个股中，Channel Therapeutics Corporation、Uniqure N.V.、硕迪生物涨幅较大，Channel Therapeutics Corporation、Clearmind Medicine Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为348.43%、130.19%、44.12%，振幅较大的相关个股有Channel Therapeutics Corporation、Celularity Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为17.53%、12.20%、9.60%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213123aa2c72cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250417213123aa2c72cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2527441751","title":"Ensysce Biosciences, Inc.盘中异动跌3.57% 换手率达29.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527441751","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527441751?lang=zh_cn&edition=full","pubTime":"2025-04-15 21:43","pubTimestamp":1744724612,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日21时43分，Ensysce Biosciences, Inc.股票出现波动，股价快速下跌3.57%。截至发稿，该股报1.89美元/股，成交量41.1781万股，换手率29.31%，振幅6.35%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214332a6bb4e86&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415214332a6bb4e86&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2527199512","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌6.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527199512","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527199512?lang=zh_cn&edition=full","pubTime":"2025-04-14 22:42","pubTimestamp":1744641750,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日22时42分，Ensysce Biosciences, Inc.股票出现异动，股价大幅跳水6.40%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为2.04%。其相关个股中，Third Harmonic Bio, Inc.、Theratechnologies Inc.、Metsera, Inc.涨幅较大，Artelo Biosciences, Inc.、Aditxt, Inc.、Hepion Pharmaceuticals, Inc.较为活跃，换手率分别为600.88%、314.60%、155.99%，振幅较大的相关个股有Artelo Biosciences, Inc.、Theratechnologies Inc.、Omniab Inc C/Wts ，振幅分别为48.91%、29.90%、25.22%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414224231aa2c6e9e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414224231aa2c6e9e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2518270347","title":"Ensysce Biosciences, Inc.盘中异动 早盘股价大跌5.38%报4.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518270347","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518270347?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:02","pubTimestamp":1741615347,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时02分，Ensysce Biosciences, Inc.股票出现波动，股价急速跳水5.38%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为669.32%、331.57%、92.62%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022022796403e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031022022796403e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENSC","BK4139"],"gpt_icon":0},{"id":"2517161383","title":"Ensysce Biosciences, Inc.盘中异动 早盘快速下跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517161383","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517161383?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:34","pubTimestamp":1741271648,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时34分，Ensysce Biosciences, Inc.股票出现波动，股价急速下跌5.01%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体跌幅为0.64%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为982.88%、121.32%、51.43%，振幅较大的相关个股有Plus Therapeutics, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Aeon Biopharma, Inc.，振幅分别为24.20%、23.12%、21.05%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223408a26290bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223408a26290bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0},{"id":"2517405479","title":"Ensysce Biosciences, Inc.盘中异动 股价大跌5.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517405479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517405479?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:46","pubTimestamp":1741196808,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时46分，Ensysce Biosciences, Inc.股票出现波动，股价大幅跳水5.39%。Ensysce Biosciences, Inc.股票所在的生物技术行业中，整体涨幅为1.23%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Nutriband Inc C/Wts 涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为941.50%、304.43%、295.24%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Ensysce Biosciences, Inc.公司简介：Ensysce Biosciences Inc 是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014648989d717e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306014648989d717e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENSC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ensysce.com","stockEarnings":[{"period":"1week","weight":-0.2188},{"period":"1month","weight":-0.0265},{"period":"3month","weight":-0.626},{"period":"6month","weight":-0.7364},{"period":"1year","weight":-0.6989},{"period":"ytd","weight":-0.6843}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ensysce Biosciences, Inc.于2003年4月在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，利用其专有技术平台开发更安全的处方药。利用其胰蛋白酶激活滥用保护和多药滥用抗性平台，该公司正在开发一类新的强大、防篡改的阿片类药物，可防止药物滥用和过量服用。预计Ensysce的产品将提供更安全的选择来治疗严重的疼痛，并有助于预防阿片类药物滥用造成的死亡，从而降低人力和经济成本。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.044599},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.166672},{"month":3,"riseRate":0.375,"avgChangeRate":-0.106138},{"month":4,"riseRate":0.25,"avgChangeRate":-0.051395},{"month":5,"riseRate":0.5,"avgChangeRate":-0.110771},{"month":6,"riseRate":0.714286,"avgChangeRate":0.045519},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.157989},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.117865},{"month":9,"riseRate":0.428571,"avgChangeRate":-0.163949},{"month":10,"riseRate":0.428571,"avgChangeRate":0.079948},{"month":11,"riseRate":0.571429,"avgChangeRate":-0.03576},{"month":12,"riseRate":0.714286,"avgChangeRate":0.198533}],"exchange":"NASDAQ","name":"Ensysce Biosciences Inc.","nameEN":"Ensysce Biosciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ensysce Biosciences Inc.,ENSC,Ensysce Biosciences Inc.股票,Ensysce Biosciences Inc.股票老虎,Ensysce Biosciences Inc.股票老虎国际,Ensysce Biosciences Inc.行情,Ensysce Biosciences Inc.股票行情,Ensysce Biosciences Inc.股价,Ensysce Biosciences Inc.股市,Ensysce Biosciences Inc.股票价格,Ensysce Biosciences Inc.股票交易,Ensysce Biosciences Inc.股票购买,Ensysce Biosciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ensysce Biosciences Inc.(ENSC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ensysce Biosciences Inc.(ENSC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}